Brandywine Global Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-75
Closed -$1K 882
2018
Q1
$1K Buy
75
+74
+7,400% +$1.38K ﹤0.01% 880
2017
Q4
$1K Hold
1
﹤0.01% 866
2017
Q3
$1K Hold
1
﹤0.01% 861
2017
Q2
$1K Hold
1
﹤0.01% 874
2017
Q1
$1K Hold
1
﹤0.01% 903
2016
Q4
$1K Sell
1
-799
-100% -$14.7K ﹤0.01% 914
2016
Q3
$20K Buy
+800
New +$20.7K ﹤0.01% 841
2016
Q2
Sell
-1,690,325
Closed -$44.5M 937
2016
Q1
$44.5M Buy
1,690,325
+828,987
+96% +$61.3M 0.29% 84
2015
Q4
$87.6M Buy
+861,338
New +$96.8M 0.56% 43

Other funds holding BHC

Brandywine Global Investment Management's BHC Position: Q2 2018 in Review

Brandywine Global Investment Management sold out of Bausch Health (BHC) in Q2 2018, closing a stake of 75 shares — an estimated $1K sold.

Brandywine Global Investment Management first reported a position in BHC in Q4 2015 and held it in 9 quarters. The position peaked at $87.6M in Q4 2015. 311 funds tracked by Wall St. Rank hold BHC as of Q2 2018.

  • Brandywine Global Investment Management reported no remaining Bausch Health position as of Q2 2018 after selling out during the quarter.
  • Brandywine Global Investment Management sold 75 Bausch Health shares in Q2 2018, an estimated $1K.
  • Brandywine Global Investment Management first reported a position in Bausch Health in Q4 2015 and held it in 9 quarters.
  • Brandywine Global Investment Management's Bausch Health position peaked at $87.6M in Q4 2015.
  • 311 funds tracked by Wall St. Rank held Bausch Health as of Q2 2018.

Based on Brandywine Global Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.